News Center

位置：

Honors Announcement

Group News

Media Reports

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2025 Southeast Asia Pharmaceutical Ingredients Exhibition

Category:

Group News

发布时间：2025-07-17

【概要描述】 The three-day 2025 Southeast Asia Pharmaceutical Ingredients Exhibition grandly opened on July 16 at the Kuala Lumpur International Trade & Exhibition Centre in Malaysia. The foreign trade team of Shijiazhuang Sihua Pharmaceutical Group showcased its core product portfolio—including finished dosage forms, active pharmaceutical ingredients, and pharmaceutical packaging materials—along with its latest R&D innovations, actively expanding into international markets and seeking collaborative opportunities.

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2025 Southeast Asia Pharmaceutical Ingredients Exhibition

The three-day 2025 Southeast Asia Pharmaceutical Ingredients Exhibition grandly opened on July 16 at the Kuala Lumpur International Trade & Exhibition Centre in Malaysia. The foreign trade team of Shijiazhuang Sihua Pharmaceutical Group showcased its core products—including finished dosage forms, active pharmaceutical ingredients, and pharmaceutical packaging materials—along with its latest R&D innovations, actively exploring international markets and seeking collaboration opportunities.
According to reports, the CPhI South East Asia exhibition is one of the most influential pharmaceutical industry events in Southeast Asia, focusing on pharmaceutical raw materials, intermediates, finished dosage forms, packaging materials, and pharmaceutical equipment. It serves as a key platform for global pharmaceutical companies to showcase innovative technologies, expand into the Southeast Asian market, and establish business partnerships. This year’s event is expected to attract more than 400 exhibitors from over 50 countries worldwide, as well as over 10,000 professional visitors.
At the exhibition, the Group showcased its core product portfolio, which includes caffeine, metronidazole, theophylline, moxifloxacin, as well as injectable and oral formulations, highlighting its integrated “API + formulation” development model. These internationally competitive flagship products—particularly the caffeine API that recently obtained EU CEP certification—have significantly enhanced the Group’s brand presence in the Southeast Asian market.
Leveraging its extensive product portfolio, the Group has garnered significant attention from numerous local Malaysian clients and customers across Southeast Asia. Industry professionals have eagerly visited the Group’s booth to engage in in-depth discussions with its sales representatives, gaining a thorough understanding of the Group’s development journey, its industrial footprint, and the technological advantages and distinctive features of its core products, including finished dosage forms, active pharmaceutical ingredients, and pharmaceutical packaging materials.
During the exhibition, the API export team of Shijiazhuang Sihua Pharmaceutical Group conducted efficient business matchmaking, holding discussions with more than 20 existing and new customers on core APIs and finished dosage forms such as caffeine, metronidazole, theophylline, and moxifloxacin, thereby laying the foundation for accelerating market expansion in Southeast Asia.
In recent years, the Group has been driven by innovation to optimize its product mix and accelerate the integration of API and formulation operations. Leveraging its advantages in digital and intelligent manufacturing as well as a green supply chain, the Group has advanced international certifications and quality audits for key products, thereby supporting its expansion into overseas markets. According to the Group’s head of foreign trade, the company will continue to deepen its “going global” strategy and steadily enhance its market presence in Southeast Asia.

Keywords:

Cultivating a Rich Talent Pool and Demonstrating Commitment to Employment | Fifty-Eight Recent Graduate Students and Undergraduates Join Shijiazhuang Sihua Pharmaceutical Group in a Collective Induction Ceremony

Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group has been recognized as an Outstanding Lean Management Enterprise in Cangzhou City for 2025.